These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26095617)

  • 41. Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
    Hansel DE; Rahman A; Hidalgo M; Thuluvath PJ; Lillemoe KD; Schulick R; Ku JL; Park JG; Miyazaki K; Ashfaq R; Wistuba II; Varma R; Hawthorne L; Geradts J; Argani P; Maitra A
    Am J Pathol; 2003 Jul; 163(1):217-29. PubMed ID: 12819026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
    Di Fiore R; Suleiman S; Pentimalli F; O'Toole SA; O'Leary JJ; Ward MP; Conlon NT; Sabol M; Ozretić P; Erson-Bensan AE; Reed N; Giordano A; Herrington CS; Calleja-Agius J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging molecular target antagonists for the treatment of biliary tract cancer.
    Lombardi P; Marino D; Fenocchio E; Chilà G; Aglietta M; Leone F
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):63-75. PubMed ID: 29468924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of MiRNA-433 in malignant tumors of digestive tract as tumor suppressor.
    Tang J; Chen J; Wang Y; Zhou S
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1694. PubMed ID: 35976177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm.
    Roshani M; Molavizadeh D; Sadeghi S; Jafari A; Dashti F; Mirazimi SMA; Ahmadi Asouri S; Rajabi A; Hamblin MR; Anoushirvani AA; Mirzaei H
    Biomed Pharmacother; 2023 Oct; 166():115264. PubMed ID: 37619484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.
    Ferreira Martins NN; da Silva Oliveira KC; Braga Bona A; de Arruda Cardoso Smith M; Ishak G; Assumpção PP; Burbano RR; Calcagno DQ
    Gastroenterol Res Pract; 2016; 2016():9797410. PubMed ID: 28115929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.
    Lyra-González I; Flores-Fong LE; González-García I; Medina-Preciado D; Armendáriz-Borunda J
    World J Hepatol; 2015 Jun; 7(11):1530-40. PubMed ID: 26085912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Roles of MicroRNAs in Breast Cancer.
    Takahashi RU; Miyazaki H; Ochiya T
    Cancers (Basel); 2015 Apr; 7(2):598-616. PubMed ID: 25860815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer.
    Han Y; Zhang H; Zhou Z; Liu R; Liu D; Bai M; Fan Q; Li J; Zhu K; Li H; Ning T; Ying G; Ba Y
    Int J Gen Med; 2021; 14():1185-1195. PubMed ID: 33833559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers.
    Gao Y; Feng B; Lu L; Han S; Chu X; Chen L; Wang R
    Oncotarget; 2017 Sep; 8(36):60624-60639. PubMed ID: 28947999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New genomic landscapes and therapeutic targets for biliary tract cancers.
    Simbolo M; Fassan M; Mafficini A; Lawlor RT; Ruzzenente A; Scarpa A
    Front Biosci (Landmark Ed); 2016 Jan; 21(4):707-18. PubMed ID: 26709801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value.
    Chira P; Vareli K; Sainis I; Papandreou C; Briasoulis E
    Cancers (Basel); 2010 Jun; 2(2):1328-53. PubMed ID: 24281118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNAs: Novel diagnostic and prognostic biomarkers in atherosclerosis.
    Siasos G; Kollia C; Tsigkou V; Basdra EK; Lymperi M; Oikonomou E; Kokkou E; Korompelis P; Papavassiliou AG
    Curr Top Med Chem; 2013; 13(13):1503-17. PubMed ID: 23745802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy of biliary tract cancer.
    Chai Y
    Tumour Biol; 2016 Mar; 37(3):2817-21. PubMed ID: 26729196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic spectra of biliary tract cancer.
    Nakamura H; Arai Y; Totoki Y; Shirota T; Elzawahry A; Kato M; Hama N; Hosoda F; Urushidate T; Ohashi S; Hiraoka N; Ojima H; Shimada K; Okusaka T; Kosuge T; Miyagawa S; Shibata T
    Nat Genet; 2015 Sep; 47(9):1003-10. PubMed ID: 26258846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
    Wheatley RC; Kilgour E; Jacobs T; Lamarca A; Hubner RA; Valle JW; McNamara MG
    Br J Cancer; 2022 Mar; 126(5):693-705. PubMed ID: 34663949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs in Human Pituitary Adenomas.
    Li XH; Wang EL; Zhou HM; Yoshimoto K; Qian ZR
    Int J Endocrinol; 2014; 2014():435171. PubMed ID: 25548562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
    Alshamrani AA
    Front Oncol; 2020; 10():1084. PubMed ID: 32850313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers.
    Nazarizadeh A; Mohammadi F; Alian F; Faraji P; Nourbakhsh M; Alizadeh-Fanalou S
    Onco Targets Ther; 2020; 13():6603-6615. PubMed ID: 32753896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expanding roles of microRNAs in kidney pathophysiology.
    Metzinger-Le Meuth V; Fourdinier O; Charnaux N; Massy ZA; Metzinger L
    Nephrol Dial Transplant; 2019 Jan; 34(1):7-15. PubMed ID: 29800482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.